The purpose of the company is to conduct research with the aim of developing and commercializing pharmaceuticals based on a patented platform for inflammation-related indications, including supportive care and applications in the central nervous system (CNS). The company may enter into research partnerships, acquire, manage and exploit patents and licenses, and conduct all business that serves to promote the company's purpose. The company may establish branches and subsidiaries in Switzerland and abroad, participate in other companies of any kind, take over representations and enter into all business and contracts that may be suitable to promote the company's purpose or are directly or indirectly related to it. It may also enter into financing for its own account or for the account of third parties, as well as guarantee, surety and pledge transactions for affiliated companies and third parties. It may acquire, lease, rent, manage, encumber and sell real estate in Switzerland and abroad. The company may acquire, hold, manage or sell any kind of debt or securities, within Switzerland or abroad.
Outbound Leads by COHAGA